Intuitive Surgical (ISRG) and Microsoft (MSFT) have recently underperformed relative to broader equity markets, but both companies present compelling long-term investment opportunities. Intuitive Surgical faces challenges from steep tariffs impacting its financials, yet it continues to show strong revenue growth driven by the adoption of its da Vinci surgical systems. The company is expanding its market share in robotic-assisted surgery and recently gained FDA clearance for new applications, solidifying its competitive edge.
Similarly, Microsoft is navigating investor skepticism regarding its AI investments, which have contributed to an 8% decline in its stock over the past year. However, the tech giant’s AI-related revenue has surged 123% year-over-year, and its cloud computing business remains robust, with a backlog that has increased by 99%. Microsoft’s strategic investments in AI and its strong financial position, evidenced by a AAA credit rating, suggest a promising outlook.
For market professionals, both stocks represent attractive buy-and-hold opportunities, particularly as they capitalize on their respective growth markets and technological advancements.
Source: fool.com